Drugs / SS1(dsFv)-PE38 immunotoxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00066651 | Jul 2003 → ? | cervical cancer, fallopian tube cancer, head and neck cancer, lung cancer +4 | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SS1(dsFv)-PE38 immunotoxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00066651 ↗ |
| Action | Deplete | “Immunotoxins can locate tumor cells and kill them without harming normal cells.” NCT00066651 ↗ |
| Route | Intravenous | “SS1(dsFv)-PE38 immunotoxin IV over 30 minutes” NCT00066651 ↗ |